checkAd

     476  0 Kommentare SuperSonic Imagine Announces the Completion of Patient Enrollment for Pivotal Liver Fibrosis Clinical Study in China - Seite 3


    Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. In addition to providing exceptional image quality, this unique technology is the foundation of several innovations which have changed the paradigm of ultrasound imaging: ShearWave™ Elastography (SWE™), UltraFast™ Doppler and more recently Angio PL.U.S - Planewave UltraSensitive™ Imaging.

    ShearWave Elastography allows physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This criteria has become an important parameter in diagnosing potentially malignant tissue or other diseased tissue. As of today, over 300 peer-reviewed publications have demonstrated the value of SWE for the clinical management of patients with a wide range of diseases. UltraFast Doppler combines Color Flow Imaging and Pulsed Wave Doppler into one simple exam, providing physicians with exam results simultaneously and helping to increase patient throughput. The latest innovation, Angio PL.U.S, provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while maintaining exceptional 2D imaging.

    SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in key global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI. SuperSonic Imagine is a listed company since April 2014 on the Euronext, symbol SSI.

    For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.

    Contact information:
    SuperSonic Imagine
    Bernard Doorenbos
    CEO
    Email Contact
    +33 6 15 66 64 68

    SuperSonic Imagine
    Marketing & Communication
    Emmanuelle Vella
    Email Contact
    +33 4 86 79 03 27

    NewCap
    Investor Relations - EU
    Pierre Laurent / Florent Alba
    Email Contact
    +33144719855

    Pascale Communication
    Media Relations - US
    Amy Phillips
    Email Contact
    +1 412 327 9499

    Seite 3 von 3



    Aktuelle Themen



    Verfasst von Marketwired
    SuperSonic Imagine Announces the Completion of Patient Enrollment for Pivotal Liver Fibrosis Clinical Study in China - Seite 3 AIX-EN-PROVENCE, FRANCE--(Marketwired - Jun 23, 2016) -  SuperSonic Imagine (EURONEXT PARIS: SSI) (FR0010526814), the highly innovative ultrasound company, announced completion of enrollment for a large prospective multicenter liver study in China. …

    Schreibe Deinen Kommentar

    Disclaimer